KAM-School of Life Sciences
Extension Number: 542
Office Number: S-349

BRIEF PROFILE
Dr Adnan Arshad has over 10 years of teaching and research experience in the field of medicine and oncology; Registered Medical Practitioner with Pakistan Medical and Dental Council; Advisor -Punjab Public Service Commission; Member Institute Review Board Fatima Memorial Hospital and Medical College, Nur Institute of research; Served as Assistant Professor Physiology- University of Lahore; Served as Clinical Research Associate – Highnoon Pharmaceuticals; Served as Clinical Research Coordinator- Shaukat Khanum Memorial Cancer Hospital and research center; Remained involved in clinical trials writing and conduct with national and international Pharmaceuticals like GSK , Sanofi Aventis etc. Life time member Pakistan Biological Safety Association; Member Clinical Research Institute UK AND American association of Clinical Research Professionals; Full registration with General Medical Council UK.

EDUCATION

• MCPS – College of Physicians and Surgeons, Pakistan
• PhD –Radiobiology- Faculty of Medicine-University of Paris 11
• MS – Oncology – Faculty of Medicine-University of Paris 11
• MBBS – Allama Iqbal Medical College-University of Punjab

RESEARCH & PUBLICATIONS
Our group at FCCU focuses on tumor microenvironment, Liquid Biopsies, Radiobiology of normal tissues and tumors, Mechanism of actions of novel anticancer compounds, Neurobiology, Nano- medicine, Entosis and Autophagy, Oncology, Immune check point modulation in carcinogenesis, Micro and Long Non coding RNAs in tumorigenesis, Orthotopic Implantation and Invivo Imaging like IVIS.

1. “Identification of Tumorigenic Markers in Head and Neck Cancer Patients, Exploring their Correlation with Tumor Aggressiveness.” Javed, N., Khaliq, H. M. H., Batool, A., Bano, K., & Arshad, A. Journal of Health and Rehabilitation Research (2023): 808-816.
2. Unraveling the Complexity of Immune Checkpoint Modulation in Gastrointestinal Malignancies. Pak-Euro Journal of Medical and Health sciences. Shoaib, M., Haseeb, H.M., Bano, K., Arshad, A. 2023: Vol. 6 No. 3, 269-276.
3. Investigating Entosis and Autophagy Dynamics in Diverse Tumor Microenvironments. Shafique.S., Khaliq. H., Bano.K., Arshad. A., Pak-Euro Journal of Medical and Health Sciences.(2023). Vol. 6 No. 4, 2023: pp. 387-394. DOI: 10.31580/pjmls.v6i4.2889
4. Mast Cells Released Inflammatory Markers Play a Vital Role in Mandibular Remodeling of Odontogenic Keratocyst Patients. Malik, Z., Mirza, A. I., Akram, M. A., Arshad, A., & Kiyani, A. Annals of King Edward Medical University. 2022 Apr 30;28(1):51-7
5. Elevated Soluble Galectin-3 as a Marker of Chemotherapy Efficacy in Breast Cancer Patients: A Prospective Study. Shafiq A, Moore J, Suleman A, Faiz S, Farooq O, Arshad A, Tehseen M et al. International Journal of Breast Cancer. 2020 Mar 14;2020:4824813.
6. Simultaneous Irradiation Of Fibroblasts and Carcinoma Cells Repress the Secretion of Soluble Factors Able to Stimulate Carcinoma Cell Migration. Arshad A, Deutsch E, Vozenin MC.PLoS One. 2015 Jan 30;10(1):e0115447.